SEC Company Response from Orthofix Medical Inc. (OFIX) (CIK 0000884624) (OFIX) — Apr 21, 2005
Orthofix Medical Inc. (OFIX) (CIK 0000884624)
Date: April 21, 2005 · CIK: 0000884624 · Accession: 0000947871-05-000829
AI Filing Summary & Sentiment
Referenced dates: April 8, 2005
Letter
[LETTERHEAD OF ORTHOFIX INTERNATIONAL N.V.] April 21, 2005 Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 Attention: Mr. Martin F. James ---------
Re: Orthofix International N.V. Form 10-K for the fiscal year ended December 31, 2004 filed March 15, 2005 Form 8-K dated March 3, 2005 filed March 3, 2005 File No. 0-19961
Dear Mr. James:
Reference is made to the above captioned Form 10-K for the fiscal year ended December 31, 2004 filed by Orthofix International N.V. (the "Company") on March 15, 2005 (the "Form 10-K"), and Form 8-K dated March 3, 2005 filed by the Company on March 3, 2005 (the "Form 8-K") and to the letter dated April 8, 2005 (the "Comment Letter") from the staff (the "Staff") of the Securities and Exchange Commission (the "Commission") regarding the Form 10-K and the Form 8-K.
The Company acknowledges that it is responsible for the adequacy and accuracy of the disclosure in the Form 10-K and the Form 8-K. The Company further acknowledges that the comments of the Staff in the Comment Letter, or any changes made to the Form 10-K and the Form 8-K in response to the Comment Letter, do not foreclose the Commission from taking any action with respect to the Form 10-K and the Form 8-K and the Company acknowledges that it may not assert the Comment Letter as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
ORTHOFIX INTERNATIONAL N.V.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
[LETTERHEAD OF ORTHOFIX INTERNATIONAL N.V.]
April 21, 2005
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Mr. Martin F. James
---------
Re: Orthofix International N.V.
Form 10-K for the fiscal year ended December 31, 2004 filed March 15, 2005
Form 8-K dated March 3, 2005 filed March 3, 2005
File No. 0-19961
Dear Mr. James:
Reference is made to the above captioned Form 10-K for the fiscal year
ended December 31, 2004 filed by Orthofix International N.V. (the "Company") on
March 15, 2005 (the "Form 10-K"), and Form 8-K dated March 3, 2005 filed by the
Company on March 3, 2005 (the "Form 8-K") and to the letter dated April 8, 2005
(the "Comment Letter") from the staff (the "Staff") of the Securities and
Exchange Commission (the "Commission") regarding the Form 10-K and the Form 8-K.
The Company acknowledges that it is responsible for the adequacy and
accuracy of the disclosure in the Form 10-K and the Form 8-K. The Company
further acknowledges that the comments of the Staff in the Comment Letter, or
any changes made to the Form 10-K and the Form 8-K in response to the Comment
Letter, do not foreclose the Commission from taking any action with respect to
the Form 10-K and the Form 8-K and the Company acknowledges that it may not
assert the Comment Letter as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.
Very truly yours,
ORTHOFIX INTERNATIONAL N.V.
By /s/ Raymond C. Kolls
--------------------------------------
Name: Raymond C. Kolls
Title: Vice President, General Counsel
& Corporate Secretary
</TEXT>
</DOCUMENT>